Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database
Table 2
Patient metastatic profile versus metastasis in the bone.
Metastasis in bone
Absent (N = 894)
Present (N = 140)
Total (N = 1034)
N (%)
N (%)
N (%)
Metastasis in soft-tissue (primary or other soft-tissue invasive)
Absent
411 (46.0)
67 (47.9)
478 (46.2)
Present
483 (54.0)
73 (52.1)
556 (53.8)
Metastasis in liver
Absent
713 (79.8)
95 (67.9)
808 (78.1)
Present
181 (20.2)
45 (32.1)
226 (21.9)
Metastasis in lymph nodes
Absent
693 (77.5)
91 (65.0)
784 (75.8)
Present
201 (22.5)
49 (35.0)
250 (24.2)
Metastasis in lung
Absent
292 (32.7)
23 (16.4)
315 (30.5)
Present
602 (67.3)
117 (83.6)
719 (69.5)
Metastasis in other sites (ascites, pleural effusion, skin, or other invasive)
